drugset / Trial / NCT00461916
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether half-dose depot triptorelin are as effective as reduced-dose daily buserelin in the controlled ovarian stimulation for intracytoplasmic sperm injection and embryo transfer
Timeline
- Start
- 2005-05
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptorelin | Other / unclassified | 1.87 mg | Intramuscular |
| Subject | buserelin | Unknown | 0.25 mg | Subcutaneous |